Alternatived Products of [ 115520-21-3 ]
Product Details of [ 115520-21-3 ]
CAS No. : 115520-21-3
MDL No. : MFCD00065639
Formula :
C43 H30 F5 NO4 S
Boiling Point :
-
Linear Structure Formula : -
InChI Key : FDAUCYDVXIPBDR-UMSFTDKQSA-N
M.W :
751.76
Pubchem ID : 11050947
Synonyms :
Chemical Name : Fmoc-Cys(Trt)-OPFP
Calculated chemistry of [ 115520-21-3 ] Expand+
Physicochemical Properties
Num. heavy atoms :
54
Num. arom. heavy atoms :
36
Fraction Csp3 :
0.12
Num. rotatable bonds :
14
Num. H-bond acceptors :
9.0
Num. H-bond donors :
1.0
Molar Refractivity :
195.14
TPSA :
89.93 ?2
Pharmacokinetics
GI absorption :
Low
BBB permeant :
No
P-gp substrate :
Yes
CYP1A2 inhibitor :
No
CYP2C19 inhibitor :
No
CYP2C9 inhibitor :
No
CYP2D6 inhibitor :
No
CYP3A4 inhibitor :
Yes
Log Kp (skin permeation) :
-3.5 cm/s
Lipophilicity
Log Po/w (iLOGP) :
5.11
Log Po/w (XLOGP3) :
10.4
Log Po/w (WLOGP) :
11.91
Log Po/w (MLOGP) :
8.35
Log Po/w (SILICOS-IT) :
10.88
Consensus Log Po/w :
9.33
Druglikeness
Lipinski :
2.0
Ghose :
None
Veber :
1.0
Egan :
1.0
Muegge :
2.0
Bioavailability Score :
0.17
Water Solubility
Log S (ESOL) :
-10.62
Solubility :
0.0000000179 mg/ml ; 0.0 mol/l
Class :
Insoluble
Log S (Ali) :
-12.23
Solubility :
0.0000000004 mg/ml ; 0.0 mol/l
Class :
Insoluble
Log S (SILICOS-IT) :
-16.34
Solubility :
0.0 mg/ml ; 4.53e-17 mol/l
Class :
Insoluble
Medicinal Chemistry
PAINS :
0.0 alert
Brenk :
3.0 alert
Leadlikeness :
3.0
Synthetic accessibility :
5.84
Safety of [ 115520-21-3 ]
Application In Synthesis of [ 115520-21-3 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Downstream synthetic route of [ 115520-21-3 ]
1
[ 14533-84-7 ]
[ 103213-32-7 ]
[ 115520-21-3 ]
2
[ 5382-16-1 ]
[ 115520-21-3 ]
N-α-Fmoc-S-trityl-L-cysteine 4-hydroxypiperidide
[ No CAS ]
3
[ 50910-54-8 ]
[ 115520-21-3 ]
N-α-Fmoc-S-trityl-L-cysteine 4-hydroxy-trans-cyclohexylamide
[ No CAS ]
4
[ 115520-21-3 ]
Leu-Phe-Leu-Gly-POEPOP-400 resin
[ No CAS ]
S-trityl-Cys-Leu-Phe-Leu-Gly
[ No CAS ]
5
[ 2654-97-9 ]
[ 115520-21-3 ]
[ 86060-92-6 ]
[ 471-25-0 ]
Fmoc-Gly-OH
[ No CAS ]
1-(1-carboxy-1-methylethyl)-1H-[1,2,3]-triazol-4-ylcarbonyl-Cys(Trt)-Phe-Gly-OH
[ No CAS ]
6
[ 50910-54-8 ]
[ 115520-21-3 ]
N-α-Fmoc-S-trityl-L-cysteine 4-hydroxy-trans-cyclohexylamide
[ No CAS ]
7
[ 115520-21-3 ]
C37 H31 NO3 (17) OS
[ No CAS ]
C37 H31 NO3 (17) OS
[ No CAS ]
8
[ 115520-21-3 ]
4-N-α-Fmoc-S-trityl-L-cysteinylpiperidyl 2-cyanoethyl N,N-diisopropyl phosphoramidite
[ No CAS ]
9
[ 115520-21-3 ]
4-trans-N-α-Fmoc-S-trityl-L-cysteinylamidocyclohexyl 2-cyanoethyl N,N-diisopropyl phosphoramidite
[ No CAS ]
10
[ 115520-21-3 ]
O-trans-4-(N-α-Fmoc-S-trityl-L-cysteinyl)aminocyclohexyl O-2-cyanoethyl-N,N-diisopropylphosphoramidite
[ No CAS ]
11
[ 771-61-9 ]
[ 115520-21-3 ]
12
[ 115520-21-3 ]
[ 3006-60-8 ]
(2R,3S,4R,5R,6S)-6-[(R)-2-([(9H-fluoren-9-yl)methoxy]carbonyl}amino)-3-oxo-3-(perfluorophenoxy)propyl]thio}-5-acetamido-2-(acetoxymethyl)tetrahydro-2H-pyran-3,4-diyl diacetate
[ No CAS ]